SUMMARY-Growth of a murine fibrosarcoma was suppressed when tumor cells were mixed with viable
INHIBITION OF TUMOR GROWTH has been achieved in several experimental systems by treatment with various infectious agents and their products (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . To date, however, clinical investigations with BCG (1), Corynebacterium parvum (13, 14) , C. granulosum (13) , and Bordetella pertussis (15) have produced only equivocal evidence for the efficacy of these agents in treatment of human cancer. More effective clinical immunotherapy might be facilitated by additional animal studies to determine the basis for the immunotherapeutic effect of different microorganisms, to define optimal conditions for the administration of these unusual antitumor agents, and to compare the relative antitumor activity of different microbes in the same tumor system.
One property shared by several bacteria that possess immunotherapeutic activity is the ability to stimulate acquired cellular immunity in the infected host. BCG (1) , Brucella abortus (7, 8) , Salmonella (9) , and Listeria monocytogenes (LM) (7) stimulate the host's immune response and can inhibit tumor growth. In previous studies we demonstrated suppression of tumor growth in mice and guinea pigs at the site of infection with BCG (16, 17) . Treatment with agents and procedures known to compromise the host's ability to control mycobacterial infection abolished the antitumor activity of BCG in these species (18, 19) .
Much is known about the development and expression of immunity to LM (20) (21) (22) . Studies of the antitumor activity of LM may further clarify the relationship between acquired cellular immunity and the inhibition of tumor growth during infection. In this paper and in a subsequent report (23) we define the antitumor activity of LM in mice and guinea pigs, comparing the effects of LM to those of BCG.
MATERIALS AND METHODS
Animals.-Male C3H/HeN mice, 18-20 g, were obtained from the breeding colony at Frederick Cancer Research Center, Frederick, Maryland. Animals were housed in groups of 6-10 in plastic cages and fed Wayne Lab Blox and tap water ad libitum.
Tumors.-Tumor 1038 was induced in 1967 by a pellet of 1% 3-methylcholanthrene in paraffin in the subcutaneous tissue of a C3H/HeNIcr male mouse (17). Transplant generations 40-54 were used in these experiments. The tumor was maintained by serial passage in immunodepressed, syngeneic mice as described in (17). Split-thickness skin grafts from C3H/-HeNIcr donors survived without contraction on normal C3H/HeN recipients for more than 100 days (17, 19) .
Tumor cell suspensions.-Tumors were excised from donor animals and placed in Dulbecco's phosphatebuffered saline (PBS) without calcium, magnesium, or antibiotics. Connective tissue and areas of necrosis were trimmed and the remaining tumor was minced into pieces 1-2 mm in greatest dimension. The minced tumor was digested for 15 minutes with 0.25% pronase and 40 /lg DNAase/ml in PBS. Digestion was repeated 3-5 times; the first batch was usually discarded as it contained many nonviable cells. Dispersed tumor cells were sedimented at 200 Xg for 10 minutes at ambient temperature, washed once, and resuspended in Hanks' balanced salt solution supplemented with 10% fetal calf serum (HBSS-FCS). A fraction of the tumor cell suspension was diluted 1: 20 with 0.13% trypan blue. Unstained cells were considered viable and counted in a hemacytometer.
Organisms.-LM, strain EGD, was maintained in a virulent state by repeated passage in mice. Organisms isolated from the spleen of an infected mouse were grown for 16-18 hours/in trypticase soy broth (TSB) , frozen, and stored at -70 0 C until use. In regression experiments, L~1 organisms were subcultured once without passage in mice. For each experiment, we enumerated colony-forming units (CFU) of L~f by diluting a portion of the inoculum in 0.9<;e I\aCI and plating samples of each dilution in brain-heart infusion agar. Colonies were counted after 48 hours' incubation at 37°C. To prepare heat-killed L~f, a suspension of viable organisms was incubated at 90°C for 60 minutes. After being heated, the bacteria were washed and lyophilized. Loss of viability was confirmed by plating of a saline suspension of lyophilized heat-killed organisms (10 mg/ml) on sheep blood agar and on brain-heart infusion agar.
BCG, Tice substrain, was obtained from the Trudeau~lycobacterial Collection (#1032). The mycobacteria were grown as a dispersed culture in~liddlebrook's medium 7H9 with 0.2S( T'''''een-80, frozen, shipped, and stored at -70°C as described in (24) . To enumerate organisms, suspensions were diluted in 0.9S( KaCI supplemented with 1sc gelatin; aliquots of appropriate dilutions were plated on Dubos oleic acid-albumin agar. Colonies were counted after 2 weeks' incubation at 37°C.
Suppression oj tumor growth.-Line-l038 fibrosarcoma cells were diluted with HBSS-FCS. L~t and BCG were diluted in the same medium.~lixtures were prepared immediately before injection. To inject the largest numbers of living L~I, organisms in undiluted TSB were mixed with equal volumes of tumor cell suspension. For tumor growth controls, tumor-cell suspensions were mixed with an equal volume of either TSB or HBSS-FCS. All injections were made intradermally (id) in a volume of 0.05 or 0.10 ml with a 27-gauge needle.~lixtures of bacteria and tumor cells were injected into skin covering the posterior dorsal surface of mice. In some experiments, tumor cells were inoculated on the dorsal surface and L~1 on the ventral surface. Animals were rechallenged by id injection of line-l038 tumor cells on the ventral surface.
Regression oj established tumor transplants.-Tumors were established by id injection of 5 Xl 0 5 line-l038 cells in 0.05 ml HBSS-FCS. At different times thereafter, suspensions of L~l or BCG were injected directly into the tumor site in 0.10 ml with a 27-gauge needle.
Immunization with LM.-~lice were immunized to LM by intravenous (iv) injection of 10 3 CFU in 0.1 ml 0.9% NaCI 11 days before the injection of tumor cells or ofLM-tumor cell mixtures (25) .
Treatment with antith)'mo~'Yte serum.-~1ice received intraperitoneal (ip) injections of 0.25 ml rabbit antiserum to mouse thymocytes (ATS; lot #13209; 1icrobiological Associates, Bethesda,~fd.) on day 5, 3, and 1 before and on day 1, 3, and 5 after injection of tumor cells with or without heat-killed L~I. One control group received ip injections of 0.25 ml normal rabbit serum (KRS) according to the same schedule. A second control group received no ip injections.
Evaluation oj tumor growth.-Mice were observed weekly for signs of progressive tumor growth. Of the animals that received line-l038 cells without L~1 or BCG, 98% (378;387) sun'i,'ed at least 2 weeks.
fice that died within 2 weeks after injection of bacteria were considered to have succumbed to bacterial infection. Tumor incidence was calculated from the number of mice sun'iving at least 2 weeks. Animals were usually obsen'ed for 90 days; in some experiments, for up to 120 days. Tumor incidence did not change after 60 days, and regression of untreated palpable tumors was not observed. Differences among groups were evaluated statistically by the Fisher exact test for groups of less than 20 and chi-square analysis for groups of more than 20.
RESULTS

Suppression of Tumor Growth With Viable LM or BeG
To determine the effect of local infection on the grov~rth of murine fibrosarcoma transplants, nonimmune mice received id injections of one of the following cell mixtures: line-l038 tumor cells plus L~I; line-l038 tumor cells plus BCG; or line-l038 tumor cells alone. The number of L~1 or BCG was varied by one-log increments in different groups. Growth of 5X 10 5 line-l038 cells could be suppressed completely by mixture with 10i viable LM immediately before transplantation, and suppression of a significant number of tumor transplants was produced with as few as 10 3 organisms ( fig. 1 ). Increase in the tumor cell inoculum appeared to increase the number of tumors that developed from tumor cells and BCG, but the differences were not statistically significant. With 5 X 10 6 line-l038 tumor cells, there was still a highly significant difference (P<O.OOI) between the effect of LM and a comparable number of BCG organisms.
Suppression of Tumor Growth With Heat-Killed LM
Having observed that a number of mice died after id injection of 10 5 -10 i viable L~1, we evaluated the antitumor activity of heat-killed organisms incapable of producing progressive infection.~1ixtu~es containing 10 2 -1 0 9 heat-killed L~1 and 5 X 10;> line-l038 tumor cells were injected id into nonimmune mice. Statistically significant suppression of tumor growth was obtained with 10 9 heat-killed organisms in each of two experiments (table 2). '\Then the dose response obtained from the combined results of these two experiments was compared to that observed in earlier studies with viable LM, the two curves appeared similar, but =100 times more heat-killed organisms 
Effect of Immunization With LM on Host Response to LMTumor Cell Mixtures
Mice given a sublethal dose of viable LM resist a second infection with numbers of organisms that would kill nonimmune animals (26) . Consequently, immunization with LM provided another method for reducing the mortality associated with the injection of 10 Contact between BCG and tumor cells appeared to be essential for optimal BCG-mediated suppression of tumors in the rat (27) , mouse (17), and guinea pig (16) . To determine whether this was also true for for the antitumor activity of LM, mice received LM and tumor cells at the same site or two different sites. Significant suppression of tumor growth was obtained when 10
-10
7 LM organisms were mixed with tumor cells before injection at the same site, but no suppression was observed when bacteria and tumor cells were injected at separate sites (table 4) .
Effect of ATS on Suppression of Murine Fibrosarcoma Transplants With Heat-Killed LM
Another requirement for BCG-mediated suppression of tumor growth is the ability of the host to respond immunologically to mycobacterial antigens (1) . Mice treated with ATS, cortisone acetate, or thymectomy and sublethal irradiation were unable to suppress the growth of fibrosarcoma transplants at sites of infection with BCG (19) . LM might suppress the growth of fibrosarcoma transplants by nonimmunologic mechanisms. Direct contact between tumor cells and LM is required for suppression of tumor growth. Hemolytic and lipolytic cytotoxins have been isolated from LM (28) and these could be tumoricidal, particularly when tumor cells and bacteria are in close association.
Results from two types of experiments suggest that direct cytotoxicity does not account for all antitumor activity of heat-killed LM. In the first experiment, 10 6 line-I038 tumor cells were mixed with 10 9 heatkilled LM and incubated in 1 ml HBSS-FCS for 2 hours at 24°C. At the beginning of incubation, 95.5% of the tumor cells excluded 0.13% trypan blue. 6 (open symbols) line-1038 cells before id injection into nonimmune syngeneic recipients. Percent tumor incidence computed from number of tumors that developed in mice surviving 2 weeks after injection of bacteriatumor cell mixtures. c TUlllor illl'.ldl1l1('(1 ill illllllUlH1 rl1dpieIlLs dill\,rs froul that. ill IlOllillllllulie n'dpi(\IlLs at }'cll.lKI~I.
"5XIOG Ihl11-103H t.ulllor l'lllls ill IlIlHH-I"CH USll(/ for llljedioll.
• 5XlO G Hue-103!) LUlllor ('ells III 'l'HIl uSNI for illjl'('UOU. c "HauH\ site" differs from "differeut. sit.e" at. P<O.ll.'). " "Hallie sito" dilfers from "diffl\f(lllt sit.o" at. P<ll.Ol.
• .')XIOG lille-103H t.ulllor colis ill IlBHS-lt'CH usod for iujectioll. f .'iXIOG Iille-W3S tUlllor cells iu 'l'SIl useO lor iujectiou.
After 2 hours, cells incubated with LM were B7.9% viable, whereas cells incubated with control medium were HU.(j(i;) viable. Lack of acute toxicity in vitro docs not rule out the possibility of direct toxicity exerted over a longer period in vivo. A second experiment was designed to elucidate events in vivo. Mice were treated with ATS before injection of tumor cells with or without addition of heat-killed LM. Additional groups were treated with NRS or were not treated prior to injection. Treatment with ATS abolished the antitumor activity of LM (table 5) . NRS increased the number of tumors developing from mixtures of LM and tumor cells relative to untreated controls (P=O.044). However, ATS was significantly more effective than the NRS (P=O.002) ,
Regression of Established Murine Fibrosarcoma Transplants
The observation that complete suppression of line-103B tumor cells could be produced at the site of infection with viable LM suggested that established transplants might also be susceptible to the antitumor activity of LM. Mice were given an id injection of 
X 10
5 line-l038 tumor cells. After 3, 7, or 11 days, 10 7 viable LM organisms in 0.1 ml TSB or an equal volume of the diluent was injected directly into the tumor site. A significant reduction in tumor incidence was achieved at 3 days when nodules averaged 1 mm in diameter, but not at 7 or 11 days when tumors averaged 4.7 and 9.7 nun, respectively (table 6). In a subsequent experiment, regression of 5-day tumor nodules measuring 2.2 mm in diameter resulted from an intratumor injection or 10 7 LM (table 7) . Multiple intratumor injections of viable LM were no more effective than a single dose (table 7) . In the same experiment, 10 7 BCG in 0.1 ml medium 7H9 did not produce a significant number of regressions when compared to a group receiving medium 7H9 alone.
In attempts to augment the antitumor activity (table 8) of LM a combination of BCG and LM was no more effective than LM alone in producing regression of 5-day tumor transplants; a tenfold increase in the number of LM injected failed to increase the number of regressions; and preimmunization with an iv dose of 10 3 LM prevented deaths from an intratumor injection of 10 8 viable LM but did not augment the antitumor activity of the organisms. Intratumor injec- of LM was superior to that of BCG. The virulence of LM, however, limited its utility as an immunotherapeutic agent. While 10 7 BCG organisms were well tolerated, the intratumor or id injection of 10 Preimmunization of the host to LM was not required for LM-mediated tumor suppression or regression. Youdim et al. (7) reported that growth of a murine fibrosarcoma could be prevented if mixtures of LM and tumor cells were injected into the foot pads of mice already immune to LM. Preliminary observations by our group (29) and Youdim (30) indicated that LM-mediated suppression of tumor growth could occur in nonimmune recipients. In this report we have compared tumor growth in LM-immune and nonimmune mice that received mixtures of LM and tumor cells. The dose of LM was varied from 1 to 10 7 organisms, and no consistent difference in tumor incidence was noted between LM-immune and nonimmune recipients.
The antitumor activity of LM cannot be attributed to the trauma of intratumor injection or to the toxicity of the medium in which the LM was grown. The incidence of tumors developing from mixtures of tumor cells and TSB was indistinguishable from that of tumors growing from suspensions of tumor cells in HBSS-FCS. Intratumor injection of TSB or medium 7H9 reduced the incidence of tumors in some experiments, but the effect was never statistically significant. LM could have exerted a direct toxic effect on tumor cells (28) , but against this possibility are two lines of evidence: Mixture of heat-killed LM with tumor cells in vitro did not reduce tumor cell viability; a similar lack of direct toxicity was observed when living LM organ"sms were mixed with murine fibrosarcoma cells (7) . Suppression of the host's immune response with ATS permitted the growth of tumors from mixtures of heat-killed LM and tumor cells. Treatment of mice with ATS inhibited the development of a primary immune response to viable LM (31) . Transfer of resistance to LM with spleen cells from LM-immune. mice was abrogated by ATS treatment of the cells or the recipient (32, 33). Elimination of the antitumor activity of heat-killed LM by ATS suggests, but does not establish, that killing of tumor cells resulted from an immune reaction to the LM.
Several parallels exist between the antitumor activity of LM and that of BCG. Treatment with ATS permitted the growth of tumors from mixtures of BCG and fibrosarcoma cells (19) . Growth of murine fibrosarcomas was suppressed with viable BCG in BCG-immune and nonimmune recipients (17). Heatkilled BCG also suppressed murine tumor growth, but when equal numbers of organisms were compared, viable BCG was more effective. Local infection with BCG did not augment systemic tumor-specific immunity to murine fibrosarcomas (17). Close contact between BCG and tumor cells was required for suppression of line-l038 fibrosarcoma growth (17). Preimmunization with BCG or injection of BCG at a separate site did not affect growth of this tumor. However, the ability of mouse fibrosarcoma transplants to grow in BCG-infected hosts varied among different tumor lines (34). Similarly, inhibition of tumor growth after systemic infection with LM might be observed with tumor lines other than 1038.
LM and BCG are obligate intracellular parasites rapidly phagocytized by reticuloendothelial cells of the infected host. Elimination of both organisms requires the presence of activated macrophages. Macrophage activation, in turn, depends on the development of a population of specifically immune, short-lived, thymus-derived lymphocytes (21) . Once activated, macrophages of BCG-immune animals can destroy various intracellular pathogens. Macrophages from mice infected with BCG (35, 36) or LM (37) can either kill or inhibit the growth of tumor cells in vitro. Macrophages and histiocytes have been observed in close association with degenerating tumor cells in vivo after intratumor injection of BCG in guinea pigs (38). These observations suggest that tumor cells may be killed by macrophages as "innocent bystanders" at sites of infection with LM or BCG. While this is an appealing model, it discounts the possible role of lymphocytes as direct effectors of tumor-cell killing. Specifically sensitized thymus-derived lymphocytes accumulate at sites of inflammation induced by LM or BCG. Although these cells are not bactericidal, lymphocytes from BCG-immune animals stimulated with purified protein derivative of tuberculin can kill tumor cells either by direct contact (35) or the release of tumoricidal lymphokines (39, 40). It is not known whether lymphocytes from LM-infected mice are similarly tumoricidal. To date it has been difficult to design experiments to delineate the relative contribution of lymphocytes and macrophages to killing of tumor cells at sites of bacterial infection. Observation of the antitumor activity of LM may facilitate these studies.
LM was more effective than BCG in producing suppression and regression of line-l038 tumor transplants. This apparent difference in antitumor activity may relate to the rapid proliferation of LM and to the early development of anti-LM immunity. After iv injection, the number of LM organisms in the liver and spleen of mice increases by 2-3 logs within 3 days (41). From 12 to 14 days are required for a 1-to 2-log increase in the number of BCG organisms after iv administration (41). The cellular immune response to LM is maximal 6 days after iv injection (42), whereas an optimal response to BCG requires 2 weeks to develop (43). Comparable differences in the kinetics of bacterial proliferation and host response would be anticipated after id injection of LM and BCG. The antitumor activity of LM and BCG appeared to depend on the number of organisms administered (tables 1, 2; text-figs. 1,2). For comparison of antitumor activity, equal numbers of CFU were injected. Within a few days, substantial differences could have developed in the number of LM and BCG organisms at the site of infection. Complete suppression of tumor growth was observed when tumor cells were mixed with 10 7 viable LM or 10 9 heat-killed LM before injection, but only partial suppression occurred with 10 7 viable BeG. Technical difficulties in concentrating BCG suspensions prevented the injection of a larger number of organisms, but complete suppression of tumor growth might have been produced had this been possible. Regression of fibrosarcoma transplants 5 days after the injection of tumor cells was accomplished by the intratumor injection of LM. Intratumor injection of BCG was no more effective than intratumor injection of diluent. Again, proliferation of LM may have been important. BCG-mediated regression of established line-l038 transplants has, however, been observed in mice previously immunized to BCG (17). The anamestic response to mycobacteria develops more rapidly than a primary response. Rapid development of an immune response to LM or to BCG may be important for the elimination of a constantly increasing tumor burden.
Studies of the effects of LM infection on other murine tumor systems may be informative. Sublethal doses of LM administered iv are eradicated by host macrophages in the liver and spleen. Data presented in this paper and in other reports (7, 16, 17, 27) suggest that tumor cells are killed when in contact with leukocytes responding to bacterial infection. Murine tumors that localize in the liver and spleen might be treated effectively by iv LM infection. Candidates for such treatment include hepatomas, leukemias, and lymphomas.
